100% Free GAQM ISO-QMS-13485 Practice Test Questions

Question 1

During an ISO 13485:2016 audit, the Lead Auditor discovers that a medical device company uses a cloud-based software to manage its training records. The software provider states the system is fully compliant with all relevant data privacy requirements such as GDPR and HIPAA. The manufacturer performs an annual review of the software provider’s SOC 2 Type II report to verify its compliance with relevant security standards. Considering the requirements of ISO 13485:2016 regarding the control of outsourced processes, what should be your MOST appropriate next action?

A : Accept the SOC 2 Type II report as sufficient evidence of compliance, and move on to another area of the audit.

B : Confirm the scope of the SOC 2 Type II report addresses the specific data privacy and security controls required by the company's QMS and applicable regulations, and verify the medical device manufacturer has performed a documented risk assessment to identify potential risks associated with data privacy.

C : Require the company to perform a full on-site audit of the software provider's facility to verify compliance with data privacy requirements.

D : Accept the software provider's statement of compliance without further verification, as cloud providers are inherently responsible for data privacy.

Answer: B

Question 2

A medical device company is undergoing an ISO 13485:2016 audit. The company has a documented procedure for design verification. As the Lead Auditor, you discover that the company has not formally validated the computer software used to perform finite element analysis (FEA) during design verification, where the FEA is part of the QMS and Clause 4.1.6 applies. The output of the FEA software is used as objective evidence that the design meets safety and performance requirements. The FEA software is commercial off-the-shelf software and not developed by the medical device manufacturer. The company states that they check the FEA software inputs and outputs against hand calculations as a form of verification. As the Lead Auditor, what is your MOST appropriate course of action?

A : Accept the company's approach because the software is commercially available and inputs and outputs are verified using hand calculations.

B : Consider the company's approach as verification and ask for the documented procedure for verification, objective evidence, and acceptance criteria for these hand calculations.

C : Document the lack of software validation as a finding and follow up during the next surveillance audit.

D : Issue a nonconformity because the FEA software used for design verification must be validated for its intended use.

Answer: D

Question 3

During an ISO 13485:2016 audit, the Lead Auditor is reviewing the effectiveness of the company's Corrective and Preventive Action (CAPA) system. The auditor notes that the company's CAPA procedure includes a requirement for effectiveness checks to verify that implemented corrective actions have been effective in addressing the root cause of the problem and preventing recurrence. However, the Lead Auditor discovers that the effectiveness checks consistently focus on confirming the immediate resolution of the problem, with limited consideration of the long-term sustainability and robustness of the implemented corrective action, or its potential unintended consequences. What is the MOST appropriate next step for the Lead Auditor to take?

A : Accept the company's approach, as the immediate resolution demonstrates the corrective action was effective.

B : Review the rationale for the short-term effectiveness checks and evaluate whether it aligns with the nature of the identified problems and the implemented corrective actions.

C : Document a minor nonconformity, since some effectiveness checks are performed, and allow the company to fix the issue after the audit.

D : Issue a major nonconformity, as the procedure is well-documented and effectiveness checks are being performed, which indicates a systematic issue.

Answer: B

Question 4

During an ISO 13485:2016 audit, the Lead Auditor is reviewing the effectiveness of the company's Corrective and Preventive Action (CAPA) system. The auditor notes that the company's CAPA procedure includes a requirement for effectiveness checks to verify that implemented corrective actions have been effective in addressing the root cause of the problem and preventing recurrence. However, the Lead Auditor discovers that the effectiveness checks consistently focus on confirming the immediate resolution of the problem, with limited consideration of the long-term sustainability and robustness of the implemented corrective action, or its potential unintended consequences. What is the MOST appropriate next step for the Lead Auditor to take?

A : Accept the company-s approach, as the immediate resolution demonstrates the corrective action was effective.

B : Review the rationale for the short-term effectiveness checks and evaluate whether it aligns with the nature of the identified problems and the implemented corrective actions.

C : Document a minor nonconformity, since some effectiveness checks are performed, and allow the company to fix the issue after the audit.

D : Issue a major nonconformity, as the procedure is well-documented and effectiveness checks are being performed, which indicates a systematic issue.

Answer: B

Question 5

During an ISO 13485:2016 audit, the Lead Auditor is reviewing the Supplier Quality Agreement between the medical device company and a contract manufacturer of a critical component. The Supplier Quality Agreement details the product specifications, quality requirements, and acceptance criteria. The Lead Auditor confirms there is evidence of recent performance data trending showing sustained compliance. However, the Lead Auditor discovers that the Supplier Quality Agreement does not define how the contract manufacturer must manage changes to its own suppliers, including sub-tier supplier changes. As a Lead Auditor, what is the MOST appropriate determination regarding the company's approach?

A : The company-s approach is acceptable because the contract manufacturer is responsible for managing their own suppliers.

B : The company-s approach is acceptable, provided the contract manufacturer is ISO 13485 certified.

C : The company-s approach is noncompliant. The medical device company should have approval authority over the contract manufacturer-s changes to sub-tier suppliers.

D : The company-s approach is acceptable because of the evidence of recent performance data trending showing sustained compliance.

Answer: C

Free Practice GAQM ISO-QMS-13485 Exam Questions 2025